Pharmacyte Biotech logo

Pharmacyte Biotech Share Price Today

(NASDAQ: PMCB)

Pharmacyte Biotech share price is $1.79 & ₹155.67 as on 6 Mar 2025, 2.30 'hrs' IST

$1.79

0.09

(5.29%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Pharmacyte Biotech share price in Dollar and Rupees. Guide to invest in Pharmacyte Biotech stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Pharmacyte Biotech, along with analyst recommendations, forecasts, and comprehensive financials.

Pharmacyte Biotech share price movements

  • Today's Low: $1.74
    Today's High: $1.80

    Day's Volatility :3.53%

  • 52 Weeks Low: $1.39
    52 Weeks High: $2.58

    52 Weeks Volatility :46.12%

Pharmacyte Biotech (PMCB) Returns

PeriodPharmacyte Biotech IncIndex (Russel 2000)
3 Months
3.66%
0.0%
6 Months
3.16%
0.0%
1 Year
-16.26%
0.0%
3 Years
-20.56%
-11.6%

Pharmacyte Biotech (PMCB) Key Statistics

in dollars & INR

Previous Close
$1.7
Open
$1.78
Today's High
$1.8001
Today's Low
$1.7366
Market Capitalization
$11.9M
Today's Volume
$1.1K
52 Week High
$2.58
52 Week Low
$1.39
Revenue TTM
$0.0
Earnings Per Share (EPS)
$0.88
PE Ratio
1.94
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
43.18%

How to invest in Pharmacyte Biotech Stock (PMCB) from India?

It is very easy for Indian residents to invest directly in Pharmacyte Biotech from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Pharmacyte Biotech stock in both Indian Rupees (INR) and US Dollars (USD). Search for Pharmacyte Biotech or PMCB on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Pharmacyte Biotech or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Pharmacyte Biotech shares which would translate to 0.486 fractional shares of Pharmacyte Biotech as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Pharmacyte Biotech, in just a few clicks!

Returns in Pharmacyte Biotech (PMCB) for Indian investors in Rupees

The Pharmacyte Biotech stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Pharmacyte Biotech investment value today

Current value as on today

₹93,140

Returns

₹6,860

(-6.86%)

Returns from Pharmacyte Biotech Stock

₹11,823 (-11.82%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Pharmacyte Biotech (PMCB)

-37%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Pharmacyte Biotech Stock from India on INDmoney has decreased by -37% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Pharmacyte Biotech

  • Vanguard Group Inc

    2.76%

  • Geode Capital Management, LLC

    2.36%

  • EQUITEC PROPRIETARY MARKETS, LLC

    1.19%

  • Renaissance Technologies Corp

    0.71%

  • Susquehanna International Group, LLP

    0.49%

  • Dimensional Fund Advisors, Inc.

    0.39%

Analyst Recommendation on Pharmacyte Biotech

Sell

    0%Buy

    50%Hold

    50%Sell

Based on 6 Wall street analysts offering stock ratings for Pharmacyte Biotech(by analysts ranked 0 to 5 stars)

Based on 6 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
0
0
0
Hold
3
3
3
Sell
3
3
3

Insights on Pharmacyte Biotech Stock (Ticker Symbol: PMCB)

  • Price Movement

    In the last 1 month, PMCB stock has moved up by 9.7%
  • PMCB vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 78.6%
  • PMCB vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 72.1%

Pharmacyte Biotech Technicals Summary

Sell

Neutral

Buy

Pharmacyte Biotech is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Pharmacyte Biotech (PMCB) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Pharmacyte Biotech Inc logo
10.39%
3.16%
-16.26%
-20.56%
-43.89%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Pharmacyte Biotech Inc logo
1.94
1.94
0.0
0.0
0.43
-0.05
NA
6.18
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Pharmacyte Biotech Inc logo
Sell
$11.9M
-43.89%
1.94
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Pharmacyte Biotech

PharmaCyte Biotech, Inc., a biotechnology company, develops and commercializes cellular therapies for cancer in the United States. Its cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types of cancer, including advanced and inoperable pancreatic cancer. The company develops CypCaps for pancreatic cancer and other solid cancerous tumors. It has a cooperation agreement with Iroquois Master Fund Ltd.; and license agreements with SG Austria Pte. Ltd. and Austrianova Singapore Pte. Ltd. to use the Cell-in-the-Box technology for cancer treatment. The company was formerly known as Nuvilex, Inc. and changed its name to PharmaCyte Biotech, Inc. in January 2015. PharmaCyte Biotech, Inc. was incorporated in 1996 and is headquartered in Las Vegas, Nevada.
Organization
Pharmacyte Biotech
Employees
2
CEO
Mr. Joshua N. Silverman
Industry
Consumer Sundries

Management People of Pharmacyte Biotech

NameTitle
Mr. Joshua N. Silverman
Interim CEO, Interim President & Interim Chairman
Mr. Carlos A. Trujillo CPA, CPA
Chief Financial Officer
Dr. Jose L. Iglesias M.D.
Consulting Chief Medical Officer
Dr. Hans-Peter Hammes
Member of Medical & Scientific Advisory Board and Consultant

Important FAQs about investing in PMCB Stock from India :

What is Pharmacyte Biotech share price today?

Pharmacyte Biotech share price today stands at $1.79, Open: $1.78 ; Previous Close: $1.70 ; High: $1.80 ; Low: $1.74 ; 52 Week High: $2.58 ; 52 Week Low: $1.39.

The stock opens at $1.78, after a previous close of $1.70. The stock reached a daily high of $1.80 and a low of $1.74, with a 52-week high of $2.58 and a 52-week low of $1.39.

Can Indians buy Pharmacyte Biotech shares?

Yes, Indians can invest in the Pharmacyte Biotech (PMCB) from India.

With INDmoney, you can buy Pharmacyte Biotech at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Pharmacyte Biotech at zero transaction cost.

How can I buy Pharmacyte Biotech shares from India?

It is very easy to buy Pharmacyte Biotech from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Pharmacyte Biotech (PMCB) be purchased?

Yes, you can buy fractional shares of Pharmacyte Biotech with INDmoney app.

What are the documents required to start investing in Pharmacyte Biotech stocks?

To start investing in Pharmacyte Biotech, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Pharmacyte Biotech Stock (PMCB)?

Today’s highest price of Pharmacyte Biotech (PMCB) is $1.80.

Today’s lowest price of Pharmacyte Biotech (PMCB) is $1.74.

What is today's market capitalisation of Pharmacyte Biotech?

Today's market capitalisation of Pharmacyte Biotech PMCB is 11.9M

What is the 52 Week High and Low Range of Pharmacyte Biotech Stock (PMCB)?

  • 52 Week High

    $2.58

  • 52 Week Low

    $1.39

What are the historical returns of Pharmacyte Biotech (PMCB)?

  • 1 Month Returns

    10.39%

  • 3 Months Returns

    3.16%

  • 1 Year Returns

    -16.26%

  • 5 Years Returns

    -43.89%

Who is the Chief Executive Officer (CEO) of Pharmacyte Biotech ?

Mr. Joshua N. Silverman is the current Chief Executive Officer (CEO) of Pharmacyte Biotech.